Replies to post #212617 on Biotech Values

[poorgradstudent]

RETA:

Actual difference in SAEs between bard and placebo in BEACON that caused the trial being terminated early occurred quite early (3-4 weeks on bard) so it wasn't really long term effect.

You're very correct that the hospitalizations occurred early. In that regard, my long term comment was made in haste.

What I was poorly trying to convey is that they're going after chronic / lifelong indications, and I'm not convinced that this brief trial properly conveys the risk/reward.

Definitely made some people money though.